Cancer is a complex disease, of which genesis and development are related to various factors. Though much progress has been made in diagnosis and therapeutics of cancer, the five-year survival rate of patients is not satisfying. The risk of relapse and drug resistence still exist. This conference aims to facilitate communication among researchers, and promote cancer therapeutics!

Focusing on tumor heterogeneity, tumor microenvironment, tumor immunity, early tumor diagnosis, this conference is one of the top-ranked meetings in the field of cancer in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of cancer therapeutics in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!